Drug metabolism in microorganisms.

Area of Science:

• Biotechnology
• Microbiology
• Drug Metabolism

Background:

• Microorganisms possess enzymes, notably cytochrome P450s (CYPs), capable of metabolizing drugs.
• Fungi (e.g., Cunninghamella spp.) and bacteria (e.g., Streptomyces) express CYPs that perform phase I oxidative reactions.
• These microbial systems mimic human drug metabolism pathways.

Purpose of the Study:

• To review the application of microbial CYPs in producing human drug metabolites.
• To explore additional uses of microbial CYPs in drug development.
• To highlight the potential of engineered microorganisms for pharmaceutical research.

Main Methods:

• Expression of microbial CYP genes (e.g., CYP102A1 from Bacillus megaterium) in hosts like E. coli.
• Utilizing wild type and recombinant microorganisms for drug transformation.
• Employing mutagenesis to generate CYP variants with enhanced metabolite production capabilities.
• Expressing human CYP isoforms in various host systems.

Main Results:

• Microbial systems effectively transform drugs into human-equivalent metabolites.
• Engineered CYP variants demonstrate significant potential for producing specific drug metabolites.
• Successful expression of human CYP isoforms in microbial hosts has been achieved.

Conclusions:

• Microbial CYPs are valuable tools for producing human drug metabolites.
• Engineered microorganisms offer a scalable and efficient platform for drug development.
• Further applications in drug discovery and development are anticipated.